Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 869 of 1,261

  1. US 8449909

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  2. US 8449875

    Targeting pseudotyped retroviral vectors

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  3. US 8449884

    Clotting factor-fc chimeric proteins to treat hemophilia

    Syntonix Pharmaceuticals, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  4. US 8450481

    Compounds for inhibiting protein aggregation, and methods for making and using them

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  5. US 8449890

    Neprilysin inhibitors

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  6. US 8450285

    Immunoregulatory peptides and methods of use

    Compass Therapeutics LLC · Granted May 28, 2013 · Expires May 23, 2033

    granted

  7. US 8450055

    Malaria antigen screening method

    United States of America as represented by the Secretary of the Air Force · Granted May 28, 2013 · Expires May 23, 2033

    granted

  8. US 8450321

    6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

    GILEAD CONNECTICUT, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  9. US 8450339

    Compositions for treatment of common cold

    Takeda Pharma A/S · Granted May 28, 2013 · Expires May 23, 2033

    granted

  10. US 8450341

    Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors

    Almirall, S.A. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  11. US 8450345

    Iminosugars and methods of treating viral diseases

    United Therapeutics Corporation · Granted May 28, 2013 · Expires May 23, 2033

    granted

  12. US 8450379

    Methods for treating migraine

    Corcept Therapeutics Incorporated · Granted May 28, 2013 · Expires May 23, 2033

    granted

  13. US 8450362

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  14. US 8450390

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted May 28, 2013 · Expires May 23, 2033

    granted

  15. US 8450470

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  16. US 8450467

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  17. US 8450532

    Compounds useful in the preparation of tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  18. US 8449877

    Pharmaceutically purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted May 28, 2013 · Expires May 23, 2033

    granted

  19. US 8450471

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted May 28, 2013 · Expires May 23, 2033

    granted

  20. US 8450062

    SOCS-3 promoter methylation in cancer

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  21. US 8450271

    Peptide-based scaffolds for cartilage regeneration and methods for their use

    Northwestern University · Granted May 28, 2013 · Expires May 23, 2033

    granted

  22. US 8450070

    Method for screening of cell-protecting agent

    Takeda Pharmaceutical Company Limited · Granted May 28, 2013 · Expires May 23, 2033

    granted

  23. US 8450299

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Teva Womans's Health, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  24. US 8450278

    MUC18 targeting peptides

    The Board of Regents of the University of Texas System · Granted May 28, 2013 · Expires May 23, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.